BackSunWay Biotech , Ltd. Overview

SunWay Biotech , Ltd. Profit Margin

Valuation check: 1271.TWO's profit margin is 9.16%, below the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

7.88%
↓ 16.99% YoY

As of Jun 2026

Annual Profit Margin (TTM)

9.16%
↑ 32.33% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

SunWay Biotech , Ltd. (1271.TWO) FAQ

SunWay Biotech , Ltd. posts a profit margin of 9.16% as of June 2026. That compares with 6.93% in the prior-year period — up 32.3% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SunWay Biotech , Ltd.'s profit margin was 6.93%. The latest reading is 9.16% — a 32.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.4% is typical. SunWay Biotech , Ltd.'s 9.16% is lower that level. That is roughly 31.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

SunWay Biotech , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 9.16% as of June 2026; use YoY and peer views to separate noise from signal.

Context for 1271.TWO's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; SunWay Biotech , Ltd.'s other metric pages and overview cover the third.